XI'AN INTERNATIONAL MEDICAL INVESTMENT COMPANY LIMITED Financials Xi'an International Medical Investment Company Limited
Equities
000516
CNE000000016
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.5 CNY | -1.79% |
|
+3.77% | -32.18% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 9,352 | 24,236 | 25,019 | 27,755 | 18,275 | 12,393 | - | - |
| Enterprise Value (EV) 1 | 9,352 | 24,236 | 25,019 | 27,755 | 18,275 | 12,393 | 12,393 | 12,393 |
| P/E ratio | -23.1 x | 629 x | -29.8 x | -23.5 x | -50.7 x | 50 x | 20.9 x | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 9.44 x | 15.1 x | 8.56 x | 10.2 x | 3.96 x | 2.06 x | 1.64 x | - |
| EV / Revenue | 9.44 x | 15.1 x | 8.56 x | 10.2 x | 3.96 x | 2.06 x | 1.64 x | - |
| EV / EBITDA | - | 62 x | -76.1 x | -55.6 x | 56.8 x | 14.7 x | 9.47 x | - |
| EV / FCF | - | - | - | - | 56.3 x | 31.3 x | 12.9 x | 19.7 x |
| FCF Yield | - | - | - | - | 1.78% | 3.19% | 7.74% | 5.08% |
| Price to Book | - | 4.95 x | 4.71 x | 6.55 x | 4.69 x | 2.82 x | 2.48 x | - |
| Nbr of stocks (in thousands) | 1,928,232 | 1,928,108 | 2,268,265 | 2,267,593 | 2,253,340 | 2,253,340 | - | - |
| Reference price 2 | 4.850 | 12.57 | 11.03 | 12.24 | 8.110 | 5.500 | 5.500 | 5.500 |
| Announcement Date | 4/28/20 | 4/14/21 | 4/27/22 | 4/18/23 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 991 | 1,607 | 2,921 | 2,711 | 4,618 | 6,015 | 7,562 | - |
| EBITDA 1 | - | 390.7 | -328.7 | -499.3 | 321.8 | 842.6 | 1,309 | - |
| EBIT 1 | - | 7.87 | -906.1 | -1,133 | -462 | 277.2 | 673.9 | - |
| Operating Margin | - | 0.49% | -31.02% | -41.78% | -10.01% | 4.61% | 8.91% | - |
| Earnings before Tax (EBT) 1 | - | 7.352 | -919.6 | -1,140 | -467.3 | 279.9 | 677.2 | - |
| Net income 1 | - | 45.36 | -822.2 | -1,177 | -368.4 | 248.1 | 598.1 | - |
| Net margin | - | 2.82% | -28.15% | -43.4% | -7.98% | 4.12% | 7.91% | - |
| EPS 2 | -0.2100 | 0.0200 | -0.3700 | -0.5200 | -0.1600 | 0.1100 | 0.2633 | - |
| Free Cash Flow 1 | - | - | - | - | 324.7 | 395.8 | 958.7 | 629.3 |
| FCF margin | - | - | - | - | 7.03% | 6.58% | 12.68% | - |
| FCF Conversion (EBITDA) | - | - | - | - | 100.89% | 46.97% | 73.22% | - |
| FCF Conversion (Net income) | - | - | - | - | - | 159.53% | 160.29% | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/28/20 | 4/14/21 | 4/27/22 | 4/18/23 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 |
|---|---|
| Net sales 1 | 1,173 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | -104.9 |
| Net margin | -8.94% |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | 4/25/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | - | 325 | 396 | 959 | 629 |
| ROE (net income / shareholders' equity) | - | 0.91% | -15.9% | -24.4% | -9.03% | 5.61% | 11.8% | - |
| ROA (Net income/ Total Assets) | - | - | - | -18.7% | - | 1.6% | 3% | - |
| Assets 1 | - | - | - | 6,307 | - | 15,506 | 19,936 | - |
| Book Value Per Share 2 | - | 2.540 | 2.340 | 1.870 | 1.730 | 1.950 | 2.220 | - |
| Cash Flow per Share 2 | - | 0.0200 | 0.2000 | 0.2000 | 0.4800 | 0.3700 | 1.190 | - |
| Capex 1 | - | - | - | 1,091 | 763 | 690 | 550 | - |
| Capex / Sales | - | - | - | 40.23% | 16.52% | 11.47% | 7.27% | - |
| Announcement Date | 4/28/20 | 4/14/21 | 4/27/22 | 4/18/23 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.5
CNY
Average target price
11
CNY
Spread / Average Target
+100.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.18% | 1.71B | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- 000516 Stock
- Financials Xi'an International Medical Investment Company Limited
